| Literature DB >> 24173827 |
Marie Fabritius1, Bernard Favrat, Haithem Chtioui, Giovanni Battistella, Jean-Marie Annoni, Monique Appenzeller, Kim Dao, Eleonora Fornari, Estelle Lauer, Jean-Frédéric Mall, Philippe Maeder, Patrice Mangin, Christian Staub, Christian Giroud.
Abstract
Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the patient, administrative, and legal consequences will be different if the subject is a regular or an occasional cannabis smoker. To this end, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) has been proposed as a criterion to help to distinguish between these two groups of users. However, to date this indicator has not been adequately assessed under experimental conditions. We carried out a controlled administration study of smoked cannabis with a placebo. Cannabinoid levels were determined in whole blood using tandem mass spectrometry. Significantly high differences in THCCOOH concentrations were found between the two groups when measured during the screening visit, prior to the smoking session, and throughout the day of the experiment. Receiver operating characteristic (ROC) curves were determined and two threshold criteria were proposed in order to distinguish between these groups: a free THCCOOH concentration below 3 µg/L suggested an occasional consumption (≤ 1 joint/week) while a concentration higher than 40 µg/L corresponded to a heavy use (≥ 10 joints/month). These thresholds were tested and found to be consistent with previously published experimental data. The decision threshold of 40 µg/L could be a cut-off for possible disqualification for driving while under the influence of cannabis. A further medical assessment and follow-up would be necessary for the reissuing of a driving license once abstinence from cannabis has been demonstrated. A THCCOOH level below 3 µg/L would indicate that no medical assessment is required.Entities:
Keywords: THCCOOH; cannabis; heavy use; occasional use; whole blood
Mesh:
Substances:
Year: 2013 PMID: 24173827 DOI: 10.1002/dta.1581
Source DB: PubMed Journal: Drug Test Anal ISSN: 1942-7603 Impact factor: 3.345